ARCHIVES

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

This article is from The Cancer Letter archive.

Vol. 23 No. 11 | March 21, 1997

Download PDF Visit The Full Archive

Related Articles

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

Standard Procedures Discarded in Review Of $20 Million in Texas Funds For Project Led by Wife of MD Anderson President

May 25, 2012

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003

NCI-Approved Clinical Trials

July 29, 2005

NCI Advisors Approve New $5 Million Program For Reagent Contracts.

July 10, 2009

In Brief: Glick, Armitage Lead ASCO; NCAB Approves Resolution Calling For Higher NIH Budget

June 2, 1995